Understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatment
Background: Understanding antiretroviral therapy (ART) adherence may assist in designing effective support interventions. Objectives: This study elicited perspectives on how to promote treatment adherence from virologically suppressed and unsuppressed patients receiving second-line ART. Methods: T...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
AOSIS
2020-08-01
|
Series: | Southern African Journal of HIV Medicine |
Subjects: | |
Online Access: | https://sajhivmed.org.za/index.php/hivmed/article/view/1107 |
id |
doaj-4895d68698eb413d870c08b434d55101 |
---|---|
record_format |
Article |
spelling |
doaj-4895d68698eb413d870c08b434d551012020-11-25T03:16:27ZengAOSISSouthern African Journal of HIV Medicine1608-96932078-67512020-08-01211e1e1010.4102/sajhivmed.v21i1.1107695Understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatmentSiphamandla B. Gumede0Willem D.F. Venter1Samanta T. Lalla-Edward2Ezintsha, a sub-division of Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa; and, Department of Interdisciplinary Social Science, Public Health, Utrecht University, Utrecht, The NetherlandsEzintsha, a sub-division of Wits Reproductive Health and HIV Institute, University of the Witwatersrand, JohannesburgEzintsha, a sub-division of Wits Reproductive Health and HIV Institute, University of the Witwatersrand, JohannesburgBackground: Understanding antiretroviral therapy (ART) adherence may assist in designing effective support interventions. Objectives: This study elicited perspectives on how to promote treatment adherence from virologically suppressed and unsuppressed patients receiving second-line ART. Methods: This was a cross-sectional study conducted with randomly selected patients active on second-line ART, from five public health facilities in the Johannesburg inner city. Data were collected on demographics, clinical information, participant’s experiences and ART knowledge. Virological failure was defined as exceeding 1000 copies/mL. Results: The study sample comprised 149 participants; of which 47.7% (n = 71) were virally unsuppressed and 69.1% (n = 103) were women; the median age of the participants was 42 years (interquartile range [IQR] 36–47 years). Experiencing medication-related difficulties in taking second-line ART (p = 0.003), finding second-line regimen more difficult to take than a first-line regimen (p = 0.001) and experiencing side effects (p 0.001) were all subjective predictors of virological failure. Participants’ recommendations for improving adherence included the introduction of a single tablet regimen (31.6%, n = 55), reducing the dosage to once daily (26.4%, n = 46) and reducing the pill size for second-line regimen (4.0%, n = 7). Conclusion: The results of this study highlight the importance of improving patients’ knowledge about adherence and motivation to continue ART use despite the persistence of side effects and difficulties with taking medication.https://sajhivmed.org.za/index.php/hivmed/article/view/1107adherenceviral load suppressionvirological failureantiretroviral therapysouth africa |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Siphamandla B. Gumede Willem D.F. Venter Samanta T. Lalla-Edward |
spellingShingle |
Siphamandla B. Gumede Willem D.F. Venter Samanta T. Lalla-Edward Understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatment Southern African Journal of HIV Medicine adherence viral load suppression virological failure antiretroviral therapy south africa |
author_facet |
Siphamandla B. Gumede Willem D.F. Venter Samanta T. Lalla-Edward |
author_sort |
Siphamandla B. Gumede |
title |
Understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatment |
title_short |
Understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatment |
title_full |
Understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatment |
title_fullStr |
Understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatment |
title_full_unstemmed |
Understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatment |
title_sort |
understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatment |
publisher |
AOSIS |
series |
Southern African Journal of HIV Medicine |
issn |
1608-9693 2078-6751 |
publishDate |
2020-08-01 |
description |
Background: Understanding antiretroviral therapy (ART) adherence may assist in designing effective support interventions.
Objectives: This study elicited perspectives on how to promote treatment adherence from virologically suppressed and unsuppressed patients receiving second-line ART.
Methods: This was a cross-sectional study conducted with randomly selected patients active on second-line ART, from five public health facilities in the Johannesburg inner city. Data were collected on demographics, clinical information, participant’s experiences and ART knowledge. Virological failure was defined as exceeding 1000 copies/mL.
Results: The study sample comprised 149 participants; of which 47.7% (n = 71) were virally unsuppressed and 69.1% (n = 103) were women; the median age of the participants was 42 years (interquartile range [IQR] 36–47 years). Experiencing medication-related difficulties in taking second-line ART (p = 0.003), finding second-line regimen more difficult to take than a first-line regimen (p = 0.001) and experiencing side effects (p 0.001) were all subjective predictors of virological failure. Participants’ recommendations for improving adherence included the introduction of a single tablet regimen (31.6%, n = 55), reducing the dosage to once daily (26.4%, n = 46) and reducing the pill size for second-line regimen (4.0%, n = 7).
Conclusion: The results of this study highlight the importance of improving patients’ knowledge about adherence and motivation to continue ART use despite the persistence of side effects and difficulties with taking medication. |
topic |
adherence viral load suppression virological failure antiretroviral therapy south africa |
url |
https://sajhivmed.org.za/index.php/hivmed/article/view/1107 |
work_keys_str_mv |
AT siphamandlabgumede understandingadherenceinvirallysuppressedandunsuppressedhumanimmunodeficiencyviruspositiveurbanpatientsonsecondlineantiretroviraltreatment AT willemdfventer understandingadherenceinvirallysuppressedandunsuppressedhumanimmunodeficiencyviruspositiveurbanpatientsonsecondlineantiretroviraltreatment AT samantatlallaedward understandingadherenceinvirallysuppressedandunsuppressedhumanimmunodeficiencyviruspositiveurbanpatientsonsecondlineantiretroviraltreatment |
_version_ |
1724636067390291968 |